TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05643911

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: HFNC
Description: In the HFNC group, patients will receive HFNC oxygen therapy for 20 minutes.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: NIV
Description: Patients will receive NIV for 20 minutes delivered with a naso-buccal or face mask according to the patient's tolerance.
Study: NCT04727398

Intervention type: DEVICE
Group type: OTHER
Intervention: Wide-field optical coherence tomography (Optovue®)
Description: Merged 4 images for wide-filed OCT-based PVD classification, 2 vertical line images and 2 horizontal line images
Study: NCT06368219

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ketamine- midazolam versus ketamine- propofol
Description: * Group A: 25 patients will receive ketamine (0.5 mg/kg) plus midazolam (0.05 mg/kg)~* Group B: 25 patients will receive ketamine (0.5 mg/kg) plus propofol (0.5 mg/kg)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ketamine- midazolam versus ketamine- propofol
Description: * Group A: 25 patients will receive ketamine (0.5 mg/kg) plus midazolam (0.05 mg/kg)~* Group B: 25 patients will receive ketamine (0.5 mg/kg) plus propofol (0.5 mg/kg)
Study: NCT06040177

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cadonilimab
Description: Cadonilimab will be administered within 2 weeks after the completion of the radiotherapy treatment once every 3 weeks (Q3W), for up to 2 years

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic radiotherapy
Description: Radiation therapy: Stereotactic radiotherapy (5-8Gy\*5F) for portal vein thrombus within 21 days after entry

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Renvatinib
Description: Renvatinib: 8mg (weight \<60kg) or 12mg (weight 60kg) once a day until disease progression, intolerable toxicity
Study: NCT06389162

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: transcranial direct current stimulation
Description: Transcranial direct current stimulation is a type of non-invasive brain stimulation that involves passing a weak current between two electrodes placed on the scalp.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation
Description: Transcranial direct current stimulation is a type of non-invasive brain stimulation that involves passing a weak current between two electrodes placed on the scalp.
Study: NCT04937530

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RT001
Description: RT001 8.64 g/d (3 capsules TID) for 1 month followed by 5.76 g/d (3 capsules BID) for an additional 11 months

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Comparator: Placebo Inactive comparator capsule 960 mg/capsule: 3 capsules TID for 4 weeks, followed by 3 capsules BID for the remaining 44 weeks.
Study: NCT05308693

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education material - Patient Compatible Stoma Educational Material
Description: It is an educational material made of rubber, similar to a stoma, that can be placed on the patient.
Study: NCT06154473

Intervention type: PROCEDURE
Intervention: Open heart surgery group.
Description: Patients undergoing open heart surgery.

Intervention type: PROCEDURE
Intervention: Percutaneous cardiovascular surgery group.
Description: Patients undergoing percutaneous cardiovascular surgery.
Study: NCT05074147

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Reduction in the duration of antibiotic therapy 3 weeks or 6 weeks
Description: Drugs :~* Rifampin (IP an PO) : 10mg/Kg/12h~* Ofloxacin (PO) : 200Mg/8h~* Levofloxacin (PO) : 500mg ot 1g/ twice a day~* Ciprofloxacin : IV : 400mg/8h if Pseud spp ; 400mg/12h for others Gram-negative bacilli strains; PO : 1gr/12h if Pseud spp ; 750mg/12h for others Gram-negative bacilli strains~* Clindamycin : 600-900mg/8h~* Fusidic Acid : 500mg/8h~* Teicoplanin : 10mg/kg/12h for 5 dosis in combination, then in monotherapy.~* Ceftasidim : 2g/8h if Pseud spp ; 2g/12h for others Gram-negative bacilli strains~* Trimethoprim-sulfamethoxazole (800mg/160mg) : once per day if patient \< 80Kg ; one and a half per day if patient \> 80Kg.~* Doxycyclin : 200mg/day~* Minocyclin : 100mg/8h to 12h~* Ceftriaxon : 1g to 2g/day in IV, IM or SC~* Cefotaxim : 1g to 2g/day in IV~* Pristinamycin : 1g thrice a day

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Reduction in the duration of antibiotic therapy 3 weeks or 6 weeks
Description: Drugs :~* Rifampin (IP an PO) : 10mg/Kg/12h~* Ofloxacin (PO) : 200Mg/8h~* Levofloxacin (PO) : 500mg ot 1g/ twice a day~* Ciprofloxacin : IV : 400mg/8h if Pseud spp ; 400mg/12h for others Gram-negative bacilli strains; PO : 1gr/12h if Pseud spp ; 750mg/12h for others Gram-negative bacilli strains~* Clindamycin : 600-900mg/8h~* Fusidic Acid : 500mg/8h~* Teicoplanin : 10mg/kg/12h for 5 dosis in combination, then in monotherapy.~* Ceftasidim : 2g/8h if Pseud spp ; 2g/12h for others Gram-negative bacilli strains~* Trimethoprim-sulfamethoxazole (800mg/160mg) : once per day if patient \< 80Kg ; one and a half per day if patient \> 80Kg.~* Doxycyclin : 200mg/day~* Minocyclin : 100mg/8h to 12h~* Ceftriaxon : 1g to 2g/day in IV, IM or SC~* Cefotaxim : 1g to 2g/day in IV~* Pristinamycin : 1g thrice a day
Study: NCT05019053

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coping Crew
Description: Coping Crew consists of five 60-minute virtual intervention sessions coinciding with five weeks of EMI. Participants will receive psychoeducation, challenge cognitive biases or mythbust, and participate in behavioral exposure and behavioral experiments. An EMI component of this treatment will be included for the purpose of treatment monitoring and homework tracking. Participation in this EMI component involves the daily report of levels of anxiety, depression, stress, and loneliness. When participants endorse elevated levels on any of these constructs, they will receive a targeted message reminding them of the topics covered in COPING CREW. One month after the intervention session, COPING CREW participants will complete follow-up questionnaires and interview. Participants will also participate in a feedback session 3 months after the intervention.
Study: NCT05703776

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nordic Walking
Description: Nordic Walking (NW) is an aerobic physical activity where regular walking is enhanced by the addition of the active use of specifically designed NW poles. The physical strain is distributed in a balanced way to various muscle groups of the whole body.
Study: NCT06103682

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ablative local therapy
Description: Stereotactic ablative radiotherapy (SABR) or interventional radiology (IR) ablation therapy
Study: NCT04869930

Intervention type: OTHER
Intervention: specimen collection
Description: participants will submit at minimum two of four required samples: fecal, urine, finger/toe-prick blood, and cheek swab, collected at home via commercially available kits

Intervention type: OTHER
Intervention: specimen collection
Description: participants will submit at minimum two of four required samples: fecal, urine, finger/toe-prick blood, and cheek swab, collected at home via commercially available kits

Intervention type: OTHER
Intervention: specimen collection
Description: participants will submit at minimum two of four required samples: fecal, urine, finger/toe-prick blood, and cheek swab, collected at home via commercially available kits
Study: NCT06025461

Intervention type: OTHER
Intervention: no intervention
Description: no intervention

Intervention type: OTHER
Intervention: no intervention
Description: no intervention

Intervention type: OTHER
Intervention: no intervention
Description: no intervention

Intervention type: OTHER
Intervention: no intervention
Description: no intervention

Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study: NCT05713370

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: high fat meal
Description: A high fat meal (milkshake) will be administered on the morning after the intervention of no exercise and no SR the night before.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: high fat meal
Description: A high fat meal (milkshake) will be administered on the morning after the intervention of no exercise and no SR the night before.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: high fat meal
Description: A high fat meal (milkshake) will be administered on the morning after the intervention of no exercise and no SR the night before.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: high fat meal
Description: A high fat meal (milkshake) will be administered on the morning after the intervention of no exercise and no SR the night before.
Study: NCT04100187

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Anti-CD19-CAR
Description: Cells extracted, followed by induction chemotherapy before CD19-CAR infusion (dose escalation.)
Study: NCT05915169

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Topical haemoglobin wound care spray
Description: It is a wound care spray used in the care of chronic wounds.
Study: NCT04987970

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(2)
Description: QD, PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKD-386(2)
Description: QD, PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D013, D326, D337
Description: QD, PO

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D013, D326, D337
Description: QD, PO
Study: NCT05911386

Intervention type: OTHER
Intervention: study of biological samples and echocardiographic data and link with need of hemodynamic support
Description: observational study : there is no intervention

Intervention type: OTHER
Intervention: study of biological samples and echocardiographic data and link with need of hemodynamic support
Description: observational study : there is no intervention

Intervention type: OTHER
Intervention: study of biological samples and echocardiographic data and link with need of hemodynamic support
Description: observational study : there is no intervention
Study: NCT06114654

Intervention type: BEHAVIORAL
Intervention: Physical Therapy
Description: Specific physical tests to assess muscle strength, ankle stability and activation of the lower extremity musculature: Single Leg Stance Test, Hurdle Step test and Single leg vertical jump.
Study: NCT05328544

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ACL reconstruction of the knee joint by arthroscopic technique, with the tibial fixation method using a bioabsorbable screw (Arthrex) with the use of autogenous cancellous bone grafts
Description: Reconstruction of the anterior cruciate ligament (ACL) of the joint the knee stabilization method, a bioabsorbable screw with the use of an autogenous spongy bone graft taken during drilling of the tibial canal into the tibial canate before inserting the screw.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ACL reconstruction of the knee joint by arthroscopic technique, with the tibial fixation method using a bioabsorbable screw (Arthrex) without the use of autogenous cancellous bone grafts
Description: Reconstruction of the anterior cruciate ligament (ACL) of the joint the knee stabilization method, a bioabsorbable screw without the use of an autogenous spongy bone graft taken during drilling of the tibial canal into the tibial canate before inserting the screw.
Study: NCT06413407

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Tai Chi Exercise
Description: Tai Chi Exercise will be applied to this group.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Receptive Music Therapy
Description: Receptive Music Therapy will be applied to this group.
Study: NCT05881993

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBP-4888
Description: siRNA therapeutic

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal Saline
Study: NCT06413407

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental
Description: Tai Chi Exercise and Receptive Music Therapy techniques will be applied together to this group.
Study: NCT04743596

Intervention type: DEVICE
Intervention: High-Definition Videobronchoscopy
Description: Endoscopic inspection and endobronchial biopsy with standard forceps during high-definition videobronchoscopy.
Study: NCT06494813

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: conventional pcr
Description: conventional pcr to study matrix metalloproteinase -9 gene polymorphismin rheumatoid arthritis

Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: conventional pcr
Description: conventional pcr to study matrix metalloproteinase -9 gene polymorphismin rheumatoid arthritis
Study: NCT05368506

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Wee1 Inhibitor ZN-c3
Description: Given PO
Study: NCT05435235

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10mg Tab
Description: One tablet daily starting 48h prior to PCI and continuing for 48h post-PCI.
Study: NCT05421520

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Artificial intelligence assisted system
Description: A deep learning-based bile duct scanning system that can prompt endoscopists to scan standard stations, identify bile ducts and stones in real time
Study: NCT05280405

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Infliximab
Description: Infliximab

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Infliximab
Description: Infliximab
Study: NCT05971329

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cervical Fusion (ZetaFuse™ Bone Graft)
Description: Fusion of the C3-C7 cervical vertebral bodies
Study: NCT05948462

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lorlatinib
Description: Participants will receive assigned dose of daily oral lorlatinib continuously for each cycle. Each cycle is 3 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin or Carboplatin
Description: Participants will receive standard of care intravenous Cisplatin or Carboplatin, both chemotherapy medications, on day 1 of each cycle every 3 weeks, for Cycles 1-4. Each cycle is 3 weeks.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Participants will receive intravenous Pemetrexed, a chemotherapy medication, on day 1 of each cycle. Each cycle is 3 weeks.
Study: NCT04315714

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga Program
Description: Six-week, twice weekly, 60-minute private yoga program (delivered online/virtually via Zoom).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga Program
Description: Six-week, twice weekly, 60-minute private yoga program (delivered online/virtually via Zoom).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga Program
Description: Six-week, twice weekly, 60-minute private yoga program (delivered online/virtually via Zoom).

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga Program
Description: Six-week, twice weekly, 60-minute private yoga program (delivered online/virtually via Zoom).
Study: NCT06313034

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breastfeeding education based on motivational interviewing technique
Description: Breastfeeding education based on motivational interviewing technique; Breast milk properties, benefits to mother and baby, breastfeeding positions, the relationship between breastfeeding and attachment, signs of hunger in the newborn, Breastfeeding frequency, duration and termination, Breast milk expressing methods, Expressions showing that the newborn has enough milk, Breast milk storage will cover the topics. These topics will be given based on motivational interviewing technique.~According to the motivational interviewing technique, the mother's intention, importance and confidence-sufficiency regarding breastfeeding will be determined and firstly, an agenda will be created on issues related to breastfeeding with the mother. Each session will be conducted by following the open-ended questioning, verification, reflective listening and summarizing approaches of the motivational interviewing technique.
Study: NCT05013463

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine Pill
Description: Oral Hydroxychloroquine, 200mg BID

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indapamide Pill
Description: Oral Indapamide, 2.5 mg OD
Study: NCT04726163

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous blind glucose measurement device (Free style Pro)
Description: A continuous blind glucose measurement device (Free style Pro) will be set up on the first day and throughout the entire hospital stay
Study: NCT05812703

Intervention type: BEHAVIORAL
Intervention: Cognitive Behavioral Therapy
Description: The participants will attend one of the behavioral group treatments programs offered by the Stanford Pain Management Center. This class may be held online via Zoom, or in person based at the Stanford Pain Management Center. The class may be recorded for training purposes. No names or images/faces will be recorded for privacy reasons. The behavioral groups are 3 types, with or without exercise/movement. Current Evidence Based treatments that are provided as standard practice include: Cognitive Behavioral Therapy Group, with movement, Acceptance and Commitment Therapy Group, with or without movement. Group participants will learn different skills in each group and develop a personalized plan to use the skills after group ends. At the end of group participants will be given an anonymous survey about the class to evaluate satisfaction of the treatment. Movement in this portion of class is designed to low impact and restorative/gentle, with no significant increases in HR \> 50% HRmax.

Intervention type: BEHAVIORAL
Intervention: Acceptance and Commitment Therapy (ACT)
Description: ACT is a 6 week behavioral group program led by a psychologist to improve psychological flexibility and reduce pain interference in patients with chronic pain.
Study: NCT06275321

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Synchronous-supervised online home-based group
Description: An online exercise program combining endurance and strength training

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise recommendation group
Description: General recommendation about physical exercise. No supervised
Study: NCT06434753

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Zinc Acexamate
Description: The experimental group will receive ACZ at a daily dose of 600 mg, equivalent to 100mg of elemental zinc (one hard gelatin capsule of 300 mg of ACZ twice a day). Treatment will be stopped when the patient presents any of the events that define the main endpoint of the study.~The control group will receive twice a day orally hard gelatin capsules, identical to those of ACZ, in color, weight and nature, but containing an inert preparation (isomaltose).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zinc Acexamate
Description: The experimental group will receive ACZ at a daily dose of 600 mg, equivalent to 100mg of elemental zinc (one hard gelatin capsule of 300 mg of ACZ twice a day). Treatment will be stopped when the patient presents any of the events that define the main endpoint of the study.~The control group will receive twice a day orally hard gelatin capsules, identical to those of ACZ, in color, weight and nature, but containing an inert preparation (isomaltose).
Study: NCT04936581

Intervention type: PROCEDURE
Intervention: Open Total Mesorectal Excision
Description: Open approach for Total Mesorectal Excision

Intervention type: PROCEDURE
Intervention: Laparoscopic Total Mesorectal Excision
Description: Laparoscopic approach for Total Mesorectal Excision
Study: NCT05812703

Intervention type: BEHAVIORAL
Intervention: Acceptance and Commitment Therapy (ACT)
Description: ACT is a 6 week behavioral group program led by a psychologist to improve psychological flexibility and reduce pain interference in patients with chronic pain.

Intervention type: BEHAVIORAL
Intervention: Moderate to high Intensity Group Exercise
Description: Group exercise led by supervised clinician with Cardiovascular focus to increase HR into zones to see adaptations to improve cardiovascular fitness.
Study: NCT04724720

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Famotidine
Description: Standard or care treatment plus prescribed famotidine

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Standard of care treatment plus placebo
Study: NCT06085066

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Ultrafiltration alone on Cardiopulmonary bypass
Description: Conventional Ultrafiltration was used on Cardiopulmonary bypass for patients who underwent open heart surgery

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Ultrafiltration followed by Modified Ultrafitration on Cardiopulmonary bypass
Description: Modified Ultrafiltration was used following the Conventional Ultrafiltration on Cardiopulmonary bypass for patients who underwent open heart surgery
Study: NCT04936581

Intervention type: PROCEDURE
Intervention: Robotic Total Mesorectal Excision
Description: Robotic approach for Total Mesorectal Excision

Intervention type: PROCEDURE
Intervention: Transanal Total Mesorectal Excision
Description: Transanal approach for Total Mesorectal Excision
Study: NCT05039112

Intervention type: DEVICE
Group type: OTHER
Intervention: Verofilcon A toric contact lenses
Description: Soft contact lenses for optical correction of astigmatism, used as indicated

Intervention type: DEVICE
Group type: OTHER
Intervention: Verofilcon A toric contact lenses
Description: Soft contact lenses for optical correction of astigmatism, used as indicated

Intervention type: DEVICE
Group type: OTHER
Intervention: Stenfilcon A toric contact lenses
Description: Soft contact lenses for optical correction of astigmatism, used as indicated

Intervention type: DEVICE
Group type: OTHER
Intervention: Stenfilcon A toric contact lenses
Description: Soft contact lenses for optical correction of astigmatism, used as indicated
Study: NCT05925010

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Supplementation with soluble fibre from guar (Optifibre©)
Description: 10g of soluble fibre from guar in the form of Optifibre© (dietary food for special medical purposes) is added to the standardized meal (Resource cereal porridge©).
Study: NCT05921227

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VAULT Phase 6
Description: VAULT is an input-based word learning intervention based on principles of statistical learning.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: VAULT Phase 6
Description: VAULT is an input-based word learning intervention based on principles of statistical learning.
Study: NCT05187923

Intervention type: DIAGNOSTIC_TEST
Intervention: Artificial Intelligence Algorithm
Description: Different machine learning and deep learning computer aided strategies for model construction and validation.

Intervention type: DIAGNOSTIC_TEST
Intervention: Artificial Intelligence Algorithm
Description: Different machine learning and deep learning computer aided strategies for model construction and validation.